Ansun Biopharma Announces First Patient Enrolled In Phase 3 Clinical Trial Evaluating DAS181 In Hospitalized, Immunocompromised Patients With Lower Respiratory Tract Parainfluenza Virus Infection - PRNewswire

Ansun Biopharma Announces First Patient Enrolled In Phase 3 Clinical Trial Evaluating DAS181 In Hospitalized, Immunocompromised Patients With Lower Respiratory Tract Parainfluenza Virus Infection  PRNewswire

SAN DIEGO, May 28, 2019 /PRNewswire/ -- Ansun Biopharma, Inc., today announced that the first patient has been enrolled in its Phase 3 clinical trial ...